Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph D Sanderson

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Clinical & Experimental Metastasis|November 21, 2007
Syndecan-1: a dynamic regulator of the myeloma microenvironmentRalph D Sanderson, Yang Yang
Plos One|March 24, 2009
Heparanase regulates levels of syndecan-1 in the nucleusLigong Chen, Ralph D Sanderson
Advances in Experimental Medicine and Biology|April 11, 2020
Heparanase: A Dynamic Promoter of Myeloma ProgressionAnurag Purushothaman, Ralph D Sanderson
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 21, 2009
Myeloma bone diseaseRalph D Sanderson, Joshua Epstein
Methods in Cell Biology|June 20, 2002
Measurements of glycosaminoglycan-based cell interactionsJ Kevin Langford, Ralph D Sanderson
Biotechniques|February 19, 2002
6xHis promotes binding of a recombinant protein to heparan sulfateH Marie Lacy, Ralph D Sanderson
Matrix Biology Plus|February 16, 2023
The glycocalyx: Pathobiology and repairJillian R Richter, Ralph D Sanderson
Journal of Cellular and Molecular Medicine|December 16, 2010
Proteoglycans in cancer biology, tumour microenvironment and angiogenesisRenato V Iozzo, Ralph D Sanderson
Matrix Biology : Journal of the International Society for Matrix Biology|June 5, 2012
Targeting heparanase for cancer therapy at the tumor-matrix interfaceRalph D Sanderson, Renato V Iozzo
Matrix Biology : Journal of the International Society for Matrix Biology|October 23, 2013
Chemotherapy stimulates syndecan-1 shedding: a potentially negative effect of treatment that may promote tumor relapseVishnu C Ramani, Ralph D Sanderson
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Clinical & Experimental Metastasis|November 21, 2007
Syndecan-1: a dynamic regulator of the myeloma microenvironmentRalph D Sanderson, Yang Yang
Plos One|March 24, 2009
Heparanase regulates levels of syndecan-1 in the nucleusLigong Chen, Ralph D Sanderson
Advances in Experimental Medicine and Biology|April 11, 2020
Heparanase: A Dynamic Promoter of Myeloma ProgressionAnurag Purushothaman, Ralph D Sanderson
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 21, 2009
Myeloma bone diseaseRalph D Sanderson, Joshua Epstein
Methods in Cell Biology|June 20, 2002
Measurements of glycosaminoglycan-based cell interactionsJ Kevin Langford, Ralph D Sanderson
Biotechniques|February 19, 2002
6xHis promotes binding of a recombinant protein to heparan sulfateH Marie Lacy, Ralph D Sanderson
Matrix Biology Plus|February 16, 2023
The glycocalyx: Pathobiology and repairJillian R Richter, Ralph D Sanderson
Journal of Cellular and Molecular Medicine|December 16, 2010
Proteoglycans in cancer biology, tumour microenvironment and angiogenesisRenato V Iozzo, Ralph D Sanderson
Matrix Biology : Journal of the International Society for Matrix Biology|June 5, 2012
Targeting heparanase for cancer therapy at the tumor-matrix interfaceRalph D Sanderson, Renato V Iozzo
Matrix Biology : Journal of the International Society for Matrix Biology|October 23, 2013
Chemotherapy stimulates syndecan-1 shedding: a potentially negative effect of treatment that may promote tumor relapseVishnu C Ramani, Ralph D Sanderson
Pageof 9